Free Trial

Synthomer (LON:SYNT) Reaches New 1-Year Low - Here's Why

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc's stock has reached a new 52-week low, trading at GBX 59.60 ($0.80) with a recent volume of around 945,823 shares.
  • Analysts have downgraded Synthomer's price targets, with Berenberg Bank lowering its target from GBX 120 to GBX 80, maintaining a "hold" rating.
  • Insider buying activity has increased, with notable purchases totaling over £54,000 ($70,000) from two insiders in early August.
  • Need better tools to track Synthomer? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Synthomer plc (LON:SYNT - Get Free Report)'s stock price hit a new 52-week low on Monday . The company traded as low as GBX 59.20 ($0.80) and last traded at GBX 59.60 ($0.80), with a volume of 945823 shares traded. The stock had previously closed at GBX 62.57 ($0.84).

Wall Street Analysts Forecast Growth

SYNT has been the subject of a number of recent analyst reports. Berenberg Bank reduced their price objective on Synthomer from GBX 120 ($1.61) to GBX 80 ($1.08) and set a "hold" rating for the company in a research note on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft reduced their price target on Synthomer from GBX 140 ($1.88) to GBX 115 ($1.55) and set a "hold" rating on the stock in a research report on Wednesday, July 30th. Finally, Jefferies Financial Group reiterated a "hold" rating and issued a GBX 100 ($1.34) price objective on shares of Synthomer in a report on Tuesday, August 5th.

View Our Latest Research Report on SYNT

Synthomer Stock Performance

The firm has a fifty day moving average price of GBX 98.97 and a two-hundred day moving average price of GBX 108.90. The stock has a market capitalization of £97.73 million, a PE ratio of -1.19, a P/E/G ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a current ratio of 1.90 and a quick ratio of 0.97.

Synthomer (LON:SYNT - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported GBX (5.40) (($0.07)) earnings per share (EPS) for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. Research analysts expect that Synthomer plc will post 12.962963 EPS for the current year.

Insider Buying and Selling

In related news, insider Uwe Halder bought 25,000 shares of the stock in a transaction dated Thursday, August 7th. The shares were purchased at an average price of GBX 64 ($0.86) per share, for a total transaction of £16,000 ($21,511.16). Also, insider Jonathan Silver purchased 59,229 shares of the stock in a transaction on Wednesday, August 6th. The shares were acquired at an average price of GBX 65 ($0.87) per share, for a total transaction of £38,498.85 ($51,759.68). Insiders have bought 124,149 shares of company stock worth $8,701,965 over the last ninety days. 28.00% of the stock is owned by corporate insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines